TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Center Bitter Over NCI’s Reacting To IOM report, Core grant Losses, Program Staff Cuts June 30, 1989